SUN PHARMA ADVANCED RESEARCH COMPANY LTD. Q3 FY26 Results
SPARCQ3 FY26 ResultsAnnounced 9 Feb, 1:30 pm| Metric | Value (₹ Cr) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 8.45 | 7.5% | 43.3% |
| Total Income | 8.45 | 7.4% | 44.0% |
| Expenditure | 76.44 | 8.6% | 19.1% |
| PBT | -80.35 | 6.0% | 1.1% |
| Net Profit | -80.42 | 6.0% | 1.1% |
| OPM | — | ||
| NPM | — | ||
| EPS | 2.48 | 6.0% | 201.2% |
Informational and educational content only. Not investment advice.